Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Yeon Hee Park, phD
CONTACT
mieun Kim, CRA
CONTACT
Lead
Samsung Medical Center
1. st line treatment * Palbociclib: A capsule will be administered once a day for 21 days and rest for 7 days (1cycle=28days) * AI treatment: D1\~28 days. Take once a day. Prescribed according to local prescribe guideline. * GnRH agonist: At D1 for every cycle with 4 week (+3days) interval via subcutaneous injection. (or ET + CDK4/6 inhibitors + GnRH agonist) 2. nd line treatment 28 days after the last treatment of 1st line treatment, randomization for 2nd line treatment is conducte to arm A(Talazoparib+Atezolizumab) and arm B(Talazoparib monotherapy) * Talazoparib: Take orally once a day at the same time * Atezolizumab: 1,200mg, at D1 of each cycle. Applicable for arm A only.
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted